Lynn Clay
Lynn Clay, Head of Specialty Care at Pfizer
- HSJ Partners
Together towards tomorrow: Unlocking the potential of gene therapies
This content has been developed and funded by Pfizer UK.
Lynn Clay, Head of Specialty Care at Pfizer
2024-01-31T06:00:00
This content has been developed and funded by Pfizer UK.
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud